Home > Insider Trading > Filing (0001181431-15-002864)

Filing Details

Accession Number:: 0001181431-15-002864
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-19 20:12:08
Reporting Period:: 2015-02-17

Filing Date:: 2015-02-19
Accepted Time:: 2015-02-19 20:12:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142750	Amn Healthcare Services Inc	AHS	Services-Help Supply Services (7363)	061500476

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410701	Ralph Henderson	12400 High Bluff Drive San Diego CA 92130	President, Healthcare Staffing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-02-17	18,400	$21.04	80,728	No	4	S	Direct
Common Stock	Disposition	2015-02-18	100	$21.01	80,628	No	4	S	Direct
Common Stock	Acquisiton	2015-02-19	4,435	$0.00	85,063	No	4	M	Direct
Common Stock	Disposition	2015-02-19	2,314	$20.69	82,749	No	4	F	Direct
Common Stock	Acquisiton	2015-02-19	3,314	$0.00	86,063	No	4	M	Direct
Common Stock	Disposition	2015-02-19	1,729	$20.69	84,334	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2015-02-19	4,435	$0.00	4,435	$0.00
Common Stock	Restricted Stock Units	Disposition	2015-02-19	3,314	$0.00	3,314	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,304			No	4	M	Direct
6,728			No	4	M	Direct

Footnotes

The sale of 18,400 shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in this row represents a weighted average price of $21.0363 per share. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The sale of 100 shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Common Stock acquired on the vesting of Restricted Stock Units.
Number of shares withheld for tax purposes.
The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
The Restricted Stock Units identified in this row were granted on January 3, 2013 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% of the original number of Restricted Stock Units granted, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) threshold for the previous fiscal year and on the second anniversary of the grant date, in the amount of 34% of the original number of Restricted Stock Units granted, should the Company achieve or exceed the specified EBITDA target for the 2014 fiscal year. The Company met its 2014 EBITDA threshold, and accordingly the Restricted Stock Units set forth in this row vested on February 19, 2015.
Restricted Stock Units do not have an expiration date.
The Restricted Stock Units identified in this row were granted on January 3, 2014 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% of the original number of Restricted Stock Units granted, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) threshold for the previous fiscal year and on the second anniversary of the grant date, in the amount of 34% of the original number of Restricted Stock Units granted, should the Company achieve or exceed the specified EBITDA target for the 2015 fiscal year. The Company met its 2014 EBITDA threshold, and accordingly the Restricted Stock Units set forth in this row vested on February 19, 2015.